• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促红细胞生成素受体在增殖性糖尿病视网膜病变患者视网膜前膜中的表达

Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy.

作者信息

Kase Satoru, Saito Wataru, Ohgami Kazuhiro, Yoshida Kazuhiko, Furudate Naoki, Saito Akari, Yokoi Masahiko, Kase Manabu, Ohno Shigeaki

机构信息

Department of Ophthalmology and Visual Sciences, Hokkaido University Graduate School of Medicine, N15 W7, Kita-ku, Sapporo 060-8638 Japan.

出版信息

Br J Ophthalmol. 2007 Oct;91(10):1376-8. doi: 10.1136/bjo.2007.119404. Epub 2007 May 23.

DOI:10.1136/bjo.2007.119404
PMID:17522145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2001006/
Abstract

PURPOSE

It is widely accepted that intravitreous levels of erythropoietin (Epo) are elevated in patients with ischaemic retinal diseases such as proliferative diabetic retinopathy (PDR). The aim of this study was to examine the expression of Epo and the Epo receptor (EpoR) in epiretinal membranes with and without diabetes.

METHODS

Eighteen epiretinal membranes (PDR (n = 10), idiopathic epiretinal membranes (IERMs) without diabetes (n = 4) and inner limiting membranes (ILMs) (n = 4)) were obtained during pars plana vitrectomy. Formalin-fixed and paraffin-embedded tissues were examined by immunohistochemistry with anti-Epo and EpoR antibodies.

RESULTS

The histopathological findings demonstrated that PDR membranes consisted of a variety of endothelial cells forming a microvascular cavity with red blood cells and non-vascular stromal mononuclear cells. Membranous and cytoplasmic immunoreactivity for EpoR was strongly detected in endothelial cells and stromal cells in all PDR patients. Although microvessels were not observed in IERMs and ILMs, immunoreactivity for EpoR was noted in the cellular component of IERMs, and was weakly detected in ILMs. Epo was not expressed in any membrane.

CONCLUSION

EpoR was strongly expressed in microvessels of all PDR membranes. The in vivo evidence in this study suggests that Epo in the vitreous binds to EpoR in PDR membranes, which subsequently leads to the proliferation of new retinal vessels. EpoR immunoreactivity in non-vascular stromal cells in PDR membranes, and IERMs and ILMs might be indirectly correlated with ischaemia.

摘要

目的

人们普遍认为,在增殖性糖尿病视网膜病变(PDR)等缺血性视网膜疾病患者中,玻璃体内促红细胞生成素(Epo)水平会升高。本研究的目的是检测糖尿病患者和非糖尿病患者视网膜前膜中Epo及Epo受体(EpoR)的表达情况。

方法

在玻璃体切割手术中获取18个视网膜前膜(10个PDR视网膜前膜、4个无糖尿病的特发性视网膜前膜(IERMs)和4个内界膜(ILMs))。用抗Epo和EpoR抗体对福尔马林固定、石蜡包埋的组织进行免疫组织化学检测。

结果

组织病理学结果显示,PDR视网膜前膜由多种内皮细胞组成,形成带有红细胞的微血管腔以及非血管性基质单核细胞。在所有PDR患者的内皮细胞和基质细胞中均强烈检测到EpoR的膜性和细胞质免疫反应性。虽然在IERMs和ILMs中未观察到微血管,但在IERMs的细胞成分中检测到EpoR免疫反应性,在ILMs中检测到的免疫反应性较弱。在任何视网膜前膜中均未检测到Epo的表达。

结论

EpoR在所有PDR视网膜前膜的微血管中均有强烈表达。本研究中的体内证据表明,玻璃体内的Epo与PDR视网膜前膜中的EpoR结合,随后导致视网膜新生血管增殖。PDR视网膜前膜、IERMs和ILMs中非血管性基质细胞中的EpoR免疫反应性可能与缺血间接相关。

相似文献

1
Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy.促红细胞生成素受体在增殖性糖尿病视网膜病变患者视网膜前膜中的表达
Br J Ophthalmol. 2007 Oct;91(10):1376-8. doi: 10.1136/bjo.2007.119404. Epub 2007 May 23.
2
Cyclo-oxygenase-2 expression in human idiopathic epiretinal membrane.人特发性眼内视网膜膜中环氧化酶-2 的表达。
Retina. 2010 May;30(5):719-23. doi: 10.1097/IAE.0b013e3181c59698.
3
Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy.αB-晶状体蛋白在人增生性糖尿病视网膜病变的视网膜前膜中的表达。
Retina. 2012 Jun;32(6):1190-6. doi: 10.1097/IAE.0b013e318233ab9c.
4
Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.野生型p53诱导的磷酸酶1在糖尿病性视网膜前膜中的表达。
Oncotarget. 2017 May 30;8(22):35532-35541. doi: 10.18632/oncotarget.16683.
5
Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体液和视网膜前膜中的心房利钠肽。
Mol Vis. 2004 Jul 15;10:450-7.
6
Upregulation of RAGE and its ligands in proliferative retinal disease.增殖性视网膜疾病中晚期糖基化终末产物受体(RAGE)及其配体的上调
Exp Eye Res. 2006 May;82(5):807-15. doi: 10.1016/j.exer.2005.09.022. Epub 2005 Dec 20.
7
Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.视网膜前膜血管生成与增殖活性的免疫组织化学研究
Int J Clin Pract. 2005 Oct;59(10):1157-61. doi: 10.1111/j.1368-5031.2005.00573.x.
8
Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.血小板反应蛋白-2 的表达作为增殖性糖尿病视网膜病变的标志物。
Acta Ophthalmol. 2013 May;91(3):e169-77. doi: 10.1111/aos.12035. Epub 2013 Feb 7.
9
Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.缺氧诱导因子-1α及其靶基因的蛋白产物在糖尿病性纤维血管性视网膜前膜中的表达
Br J Ophthalmol. 2007 Jun;91(6):822-6. doi: 10.1136/bjo.2006.109876. Epub 2007 Jan 17.
10
Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.视网膜前膜和糖尿病视网膜病变中的细胞外基质蛋白
Curr Eye Res. 2009 Feb;34(2):134-44. doi: 10.1080/02713680802585946.

引用本文的文献

1
Characteristics and outcomes of full-thickness macular holes created during vitrectomy for proliferative diabetic retinopathy.增生性糖尿病视网膜病变玻璃体切除术后全层黄斑裂孔的特征和结局。
Int Ophthalmol. 2023 Oct;43(10):3479-3490. doi: 10.1007/s10792-023-02753-8. Epub 2023 Jun 5.
2
Reduction of Laser-Induced Choroidal Neovascularization in Mice With Erythropoietin RNA Interference.用红细胞生成素 RNA 干扰减少小鼠的激光诱导脉络膜新生血管。
Transl Vis Sci Technol. 2022 Aug 1;11(8):1. doi: 10.1167/tvst.11.8.1.
3
Systemic and vitreous biomarkers - new insights in diabetic retinopathy.系统和玻璃体生物标志物——糖尿病视网膜病变的新见解。
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2449-2460. doi: 10.1007/s00417-022-05624-7. Epub 2022 Mar 24.
4
Full-thickness macular hole formation in proliferative diabetic retinopathy.增生性糖尿病性视网膜病变中全层黄斑裂孔的形成。
Sci Rep. 2021 Dec 13;11(1):23839. doi: 10.1038/s41598-021-03239-2.
5
Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.新生血管性青光眼和增殖性糖尿病视网膜病变眼内液和玻璃体内血管生成和炎症生物标志物水平。
Int Ophthalmol. 2020 Feb;40(2):467-475. doi: 10.1007/s10792-019-01207-4. Epub 2019 Dec 4.
6
Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.促红细胞生成素受体活性对急性肾损伤中血管生成、肾小管损伤和纤维化的影响:一种“U 型”关系。
Am J Physiol Renal Physiol. 2018 Apr 1;314(4):F501-F516. doi: 10.1152/ajprenal.00306.2017. Epub 2017 Nov 29.
7
Revisiting the role of erythropoietin for treatment of ocular disorders.重新审视促红细胞生成素在眼部疾病治疗中的作用。
Eye (Lond). 2016 Oct;30(10):1293-1309. doi: 10.1038/eye.2016.94. Epub 2016 Jun 10.
8
Clinical and histological features of epiretinal membrane after diabetic vitrectomy.糖尿病玻璃体切除术后视网膜前膜的临床和组织学特征。
Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):401-10. doi: 10.1007/s00417-013-2479-0. Epub 2013 Oct 15.
9
Erythropoetin receptor expression in the human diabetic retina.促红细胞生成素受体在人类糖尿病视网膜中的表达。
BMC Res Notes. 2009 Nov 25;2:234. doi: 10.1186/1756-0500-2-234.
10
Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.促红细胞生成素小干扰RNA对增殖性视网膜病变小鼠模型视网膜新生血管形成的抑制作用
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329-35. doi: 10.1167/iovs.08-2521. Epub 2008 Oct 24.

本文引用的文献

1
Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.缺氧诱导因子-1α及其靶基因的蛋白产物在糖尿病性纤维血管性视网膜前膜中的表达
Br J Ophthalmol. 2007 Jun;91(6):822-6. doi: 10.1136/bjo.2006.109876. Epub 2007 Jan 17.
2
Expression of erythropoietin receptor in human Merkel cell carcinoma of the eyelid.促红细胞生成素受体在人眼睑默克尔细胞癌中的表达。
Anticancer Res. 2006 Nov-Dec;26(6B):4535-7.
3
Erythropoietin biology in cancer.癌症中的促红细胞生成素生物学
Clin Cancer Res. 2006 Jan 15;12(2):332-9. doi: 10.1158/1078-0432.CCR-05-1771.
4
Expression of glutamine synthetase and cell proliferation in human idiopathic epiretinal membrane.谷氨酰胺合成酶在人特发性视网膜前膜中的表达及细胞增殖
Br J Ophthalmol. 2006 Jan;90(1):96-8. doi: 10.1136/bjo.2005.078394.
5
Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy.
Diabetes Care. 2005 Sep;28(9):2252-4. doi: 10.2337/diacare.28.9.2252.
6
Angiogenic pathways in diabetic retinopathy.糖尿病视网膜病变中的血管生成途径。
N Engl J Med. 2005 Aug 25;353(8):839-41. doi: 10.1056/NEJMe058142.
7
Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.促红细胞生成素作为增殖性糖尿病视网膜病变中的一种视网膜血管生成因子。
N Engl J Med. 2005 Aug 25;353(8):782-92. doi: 10.1056/NEJMoa041773.
8
Prognostic significance of erythropoietin expression in human endometrial carcinoma.促红细胞生成素在人子宫内膜癌中的表达的预后意义。
Cancer. 2004 Jun 1;100(11):2376-86. doi: 10.1002/cncr.20244.
9
Elevated erythropoietin in vitreous with ischemic retinal diseases.缺血性视网膜疾病患者玻璃体中促红细胞生成素升高。
Neuroreport. 2004 Apr 9;15(5):877-9. doi: 10.1097/00001756-200404090-00029.
10
Important causes of visual impairment in the world today.当今世界视力损害的重要原因。
JAMA. 2003 Oct 15;290(15):2057-60. doi: 10.1001/jama.290.15.2057.